Trials

A multi-center, phase I/II study of BAY86-9766 in combination with gemcitabine in patients with locally advanced inoperable or metastatic pancreatic cancer

Cancer type: Pancreatic cancer

Phase: II

Principal Investigator: Dajani Olav

Country: NO

Keywords: Norway, Pancreatic cancer, MEK-inhibitor

Status: Completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01251640?term=BAY86-9766&rank=4